Acute myeloid leukemia (AML) remains one of the most difficult blood cancers to treat. Although drug combinations are often more effective than single agents, their true mechanisms of action have been ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

From the moment 4-year-old Cameron first stepped out into Glimmer in Spyro 2, he knew video games were going to play a central role in the rest of his life. Though he never planned to make it the ...

WASHINGTON – Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled ...

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...

A combination of outreach methods – including texts, automated messages, and live phone calls – can significantly improve follow-up care for hard-to-reach patients after they have been discharged, ...

Perimenopausal women face increased pregnancy-related risks, necessitating continued contraceptive use until menopause is confirmed. Healthy women can use combination hormonal contraceptives until mid ...

Below, an edit of the best options well regarded by three board-certified dermatologists who reveal their favorite moisturizers for combination skin, from gel-creams to lightweight lotions. Each one ...

Cancer treatment has made remarkable strides. New drugs and technologies have changed outcomes for many patients, turning some once-fatal diagnoses into manageable conditions. Yet despite these ...

The challenge takes place from July 11-20 in designated South Florida locations. Participants compete for prizes, including $10,000 for removing the most pythons. Pythons must be killed humanely using ...

Efficacy and safety of second-line lenvatinib after progression on immunotherapy in advanced hepatocellular carcinoma: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the ...